Gibbon JHArtificial maintenance of circulation during experimental occlusion of the pulmonary arteryArch Surg1937; 34: 1105-31.
2.
Gibbon JHAn oxygenator with a large surface-volume ratioJ Lab Clin Med1939b: 24 : 1192-98.
3.
Gibbon JHApplication of a mechanical heart and lung apparatus to cardiac surgeryMinnesota Med1954; 37 : 171-85.
4.
Vasko JS, Dearing JPTechniques of cardiopulmonary perfusion In: Norman JC ed. Cardiac surgery. New York: Appleton-Century-Crofts , 1972.
5.
Wernecke H., Iversen S., Hetzer R.Improved safety of hypothermic arrest by low flow bypassThorac Cardiovasc Surg1983; 31: 12-18.
6.
Astrup J., Symon L., Branston MN et al.Cortical evoked potential and intracellular K + and H+ at critical levels of brain ischaemiaStroke1977; 8: 51-58.
7.
Taylor KM, Bain WH, Russell M. et al.Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypassThorax1979; 34: 594-98.
8.
Taylor KM, Casals J., Morton JJ et al.The haemodynamic effects of angiotensin blockade after cardiopulmonary bypassBr Heart J1979; 41: 380-84.
9.
Taylor KM, Bain WH, Morton JJ et al.The role of angiotensin II in the development of peripheral vasoconstriction during open heart surgery. Am Heart J1980; 100 : 935-37.
10.
Matsumoto T. , Wolferth CC, Perlman MHEffect of pulsatile and nonpulsatile perfusion upon certain cerebral and conjunctival circulation in dogsAm Surg1971; 37 : 61-64
11.
Taylor KM, Walker MS, Rao Lgs et al.Plasma levels of cortisol, free cortisol and corticotrophin during cardiopulmonary bypassJ Endocrinol1975; 67:29-30.
12.
Taylor KM, Walker MS, Rao Lgs et al.The cortisol response during heart-lung bypassCirculation1976; 54 : 20-26.
13.
Taylor KM, Wright GS, Bremner WFAnterior pituitary response to TRH during open heart surgeryCardiovasc Res1978; 12 : 114-19.
14.
Taylor KM, Wright GS, Reid JM et al.Comparative studies of pulsatile and non-pulsatile flow during cardiopulmonary bypass. II: The effects on adrenal secretion of cortisolJ Thorac Cardiovasc Surg1978; 75: 574-78.
15.
Taylor KM, Wright GS, Bain WH et al.Comparative studies of pulsatile and non-pulsatile flow during cardiopulmonary bypass. III: Anterior pituitary response to thyrotrophin releasing hormoneJ Thorac Cardiovasc Surg1978; 75: 579-84.
16.
Tranmer BI, Gross CE, Kindt GW, Adey GRPulsatile versus non-pulsatile blood flow in the treatment of acute cerebral ischaemiaNeurosurgery1986 ;19:724-27.
17.
Masters RGThe superiority of the membrane oxygenatorJ Cardiothoracic Anesthesia1989; 3 : 235-37.
Gu YJ, Wang YS, Chiang BY, Gao XD, Ye CXMembrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypassAnn Thorac Sur1991;51: 513-78.
20.
Blauth C., Kohner EM, Arnold J. et al.Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiographyLancet1986;11:837-38.
21.
Blauth CI, Arnold JVShulenberg WE et al.Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiographyJ Thorac Cardiovasc Surg1988; 95: 668-76.
22.
Reeves RBThe interaction of body temperature and acid-base balance in ectothermic vertebratesAnn Rev Physiol1977 ; 39: 559-86.
23.
White FNA comparative physiological approach to hypothermiaJ Thorac Cardiovasc Surg1977; 82: 821-28.
24.
Henriksen L. , Hjelms E., Lindeburgh T.Brain hyperperfusion during cardiac operations. Cerebral blood flow measured in man by intra-arterial injection of xenon 133: evidence suggestive of intraoperative microembolismJ Thorac Cardiovasc Surg1987: 86: 202-208.
25.
Lundar T., Froysalter T., Lindegaard KF et al.Some observations on cerebral perfusion during cardiopulmonary bypassAnn Thorac Surg1985; 39: 318-23.
26.
Murkin JMBlood gases should not be corrected for temperature during hypothermic cardiopulmonary bypass: alpha-stat modeJ Thorac Cardiovasc Surg1988: 99: 1022-29.
27.
Prough DS, Stump DA, Roy RC et al.Response of cerebral blood flow to changes in carbon dioxide tension during hypothermic cardiopulmonary bypassAnesthesiology1986; 64: 516-19.
28.
Govier AV, Reeves JG, McKay RD et al.Factors and their influence on regional cerebral blood flow during nonpulsatile cardiopulmonary bypassAnn Thorac Surg1984; 38: 592-95.
29.
Moat NE, Shore DE, Evans TEOrgan dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteinsEur J Cardiothorac Surg1993; 7: 563-73.
30.
Kirklin JW, Donald DE, Harshbarger HG, Hetzel PS et al.Studies in extracorporeal circulation 1. Applicability of Gibbon-type pump-oxygenator to human intracardiac surgery: 40 casesAnn Surg1956; 144 : 2-8.
31.
Breuer AC, Furlan AJ, Hanson MR et al.Central nervous system complications of coronary artery bypass graft surgery: a prospective analysis of 421 patientsStroke1983; 14: 682-87.
32.
Clanivet JL , Larbuisson R., Damas P. et al.Plasma renin activity and urine beta 2-microglobulin during and after cardiopulmonary bypass: pulsatile vs nonpulsatile perfusion. Eur Heart J1990; 11: 1079-82.
33.
Royston D., Fleming J., Desai J. et al.Changes in alveolar capillary barrier function associated with cardiopulmonary bypassBr J Anaesth1986; 54: 917-21.
34.
Kirklin J.Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass [editorial comment]Ann Thorac Surg1991; 51: 529-31.
35.
Messent M., Sullivan K., Keogh B. et al.Adult respiratory distress syndrome following cardiopulmonary bypassAnaesthesia1992; 47: 267-68.
36.
Kirklin JK, Westaby S., Blackstone EH et al.Complement and the damaging effect of cardiac surgeryJ Thorac Cardiovasc Surg1983 ; 86: 845-52.
37.
Westaby S., Fleming J., Royston D.Acute lung injury during cardiopulmonary bypass, the role of neutrophil sequestration and lipid peroxidationTrans Am Soc AIO1985; 31: 604-609.
Shaw PJ, Bates D., Cartlidge Nef et al.Early neurological complications of coronary bypass surgeryBr Med J1985; 291: 1384-87.
40.
Shaw PJ, Bates D., Cartlidge Nef et al.Early intellectual dysfunction following coronary bypass surgeryQ J Med1986; 225: 59-68.
41.
Shaw PJ, Shaw DAPsychiatry morbidity following cardiac surgery: a review In: Davidson K, Ken A eds Contemporary themes in psychiatry.London: Gaskell1989.
42.
Smith Plc, Newman S., Treasure T. et al.Cerebral consequences of cardiopulmonary bypassLancet1986;i:823-24.
43.
Pugsley W., Klinger L., Paschalis C. et al.Microemboli and cerebral impairment during cardiac surgeryVascular Surgery1990; 24(1): 34-43.
44.
Elliot M.Perfusion for paediatric open heart surgerySemin Thorac Cardiovasc Surg1990; 2 : 332-40.
45.
Lee Whj, Krumhaar D., Fonkalsrud EW et al.Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operationsSurgery1961; 50: 29-33.
46.
Solis RT, Kennedy PS, Beall AC et al.Cardiopulmonary bypass: microembolization and platelet aggregationCirculation1975; 52: 103-108.
47.
Parker DJ, Cantrell JW, Karp RB et al.Changes in serum complement and immunoglobulins following cardiopulmonary bypassSurgery1972; 71:824-27.
48.
Chenoweth DE , Cooper SW, Hugli TE et al.Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxinsN Engl J Med1981; 304: 497-503.
Gerard C., Gerard NPC5a anaphylatoxin and its seven transmembrane segment receptorsAnnual review of Immunology1994; 12: 775-808.
55.
Jansen NJ, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L., Wildevuur CREndotoxin release and tumour necrosis factor formation during cardiopulmonary bypassAnn Thorac Surg1992; 54: 744-47.
56.
Taggart DP, Sundaram S., McCartney C. et al.Endotoxaemia, complement, and white blood cell activation in cardiac surgery: a randomized trial of laxatives and pulsatile perfusionAnn Thorac Surg1994 ; 57: 376-82.
57.
Vidern V., Mollnes TEHuman complement activation by polygeline and dextran 70Scand J Immunol1994; 39: 314-20.
58.
Pekna M., Nilsson L., Nilsson-Ekdahl K., Nilsson UR, Nilsson B.Evidence for iC3 generation during cardiopulmonary bypasses the result of blood-gas interactionClinical Experimental Immunology1993; 91: 404-409.
59.
Hirayama T. , Yamaguchi H., Allers M. et al.Evaluation of red cell damage during cardiopulmonary bypassScand J Cardiovasc Surg1985; 19: 263--65.
60.
Hoffman J.Cation transport and structure of the red cell plasma membraneCirculation1962; 26 : 1201-13.
61.
Westaby S.Complement and the damaging effects of cardiopulmonary bypassThorax1983; 38: 321-25.
62.
Kreel I., Zaroff L., Canter J. et al.A syndrome following total body perfusionSurg Gynecol Obstet1960;111:317-21.
63.
Schmid-Schonbein H., Born G., Richardson P. et al.ADP release from red cells subjected to high shear stress In: Schmid-Schonbein H, Teitel P eds. Basic aspects of blood trauma.The Hague , The Netherlands: Nijhoff: 1979 : 99-106.
64.
Hirayama T. , Yamaguchi H., Allers M. et al.Association between bleeding and red cell deformability following cardiopulmonary bypassScand J Cardiovasc Surg1988; 22: 171-74.
Haga Y., Hatori N., Yoshizu H., Okuda E., Uriuda Y., Tanaka S.Granulocyte superoxide anion and elastase release during cardiopulmonary bypassArtif Organs1993; 17: 837-42.
73.
Colman RWPlatelet and neutrophil activation in cardiopulmonary bypassAnn Thorac Surg1990; 48 : 32-34.
74.
Faymonville ME , Pincemail J., Duchateau J. et al.Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypassJ Thorac Cardiovasc Surg1991; 102: 309-17.
75.
Gadaleta D. , Fahey AL, Verma M. et al.Neutrophil leukotriene generation after cardiopulmonary bypassJ Thorac Cardiovasc Surg1994; 108: 642-47.
76.
Gillinov AM , Redmond JM, Winkelstein JA et al.Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dogAnn Thorac Surg1994a; 57 : 345-52.
77.
Frering B., Philip I., Dehoux M., Rolland C., Langlois JM, Desmonts JMCirculating cytokines in patients undergoing normothermic cardiopulmonary bypassJ Thorac Cardiovasc Surg1994 ; 108: 642-47.
78.
Anderson LW , Baek L., Degn H. et al.Presence of circulating endotoxins during cardiac operationsJ Thorac Cardiovasc Surg1987; 93: 115-19.
79.
Baeuerle PA , Henkel T.Function and activation of NF-kappa B in the immune systemAnn Rev Immunol1943;12: 141-79.
80.
Kusserow B. , Larrow R., Nichols J.Perfusion and surface induced injury in leucocytesFed Proc1971; 30: 1516-20.
81.
Tonnesen E. , Wahlgreen C.Influence of extradural and general anaesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomyBr J Anaesth1988; 6: 500-507.
82.
van Velzen-Blad H., Dijkstra YJ, Heijnen CJCardiopulmonary bypass and host defense functions in human beings, lymphocyte functionAnn Thorac Surg1985: 39 : 212-17.
83.
Kress HG, Gehrsitz P., Elert O.Predictive value of skin test in neutrophil migration and C-reactive protein for post-operative infections in cardiopulmonary bypass patientsActa Anaesthesiol Scand1987; 31: 397-404.
84.
Larmi Tki, Karkola P.Plasma protein electrophoresis during a three hour cardiopulmonary bypass in dogsScand J Thorac Cardiovasc Surg1974: 8: 152-57.
85.
Hennessy VL , Hicks RE, Niewiarowsk Si et al. Function of human platelets during extracorporeal circulationAm J Physiol1977; 232 : 622-28.
86.
Salzman EWBlood platelets and extracorporeal circulationTransfusion1963; 3 : 274-77.
87.
Watkins DM, Peterson MB, Kong DL et al.Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flowJ Thorac Cardiovasc Surg1982; 84: 250-56.
88.
Harker LA, Malpass TW, Branson HE et al.Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass, acquired transient platelet defect associated with alpha granule releaseBlood1980; 56: 824-34.
89.
Musial J., Niewiarowski S., Hershock D. et al.Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulationJ Lab Clin Med1985;105:514-26.
90.
Zilla P., Fasol R., Groscurth P. et al.Blood platelets in cardiopulmonary bypass operationsJ Thorac Cardiovasc Surg1989; 97: 379-88.
91.
Ratcliff NB , Young WG, Hackett DB et al.Pulmonary injury secondary to extracorporeal circulationJ Thorac Cardiovasc Surg1973; 65 : 425-31.
92.
Haslett C., Worthen GS, Giclas PC et al.The pulmonary vascular sequestration of neutrophils in endotoxaemia is initiated by an effect of endotoxin on the neutrophil in the rabbitAm Rev Resp Dis1987 ; 136: 11-19.
93.
Royston D., Fleming JS, Desai JB et al.Increased peroxide generation associated with open heart surgery: evidence for free radical generationJ Thorac Cardiovasc Surg1986; 91: 759-66.
94.
Kharazmi A. , Andersen LW, Baek L. et al.Endotoxaemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypassJ Thorac Cardiovasc Surg1989 ; 98: 381-85.
95.
Fountain SW , Marrin BAMusclow CE et al.Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbitsCirc Res1980; 46 : 175-80.
96.
McDonald JW , Ali M., Morgan E. et al.Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheepCirc Res1983; 52: 1-6.
97.
Till GO, Johnson KJ, Kunkel R.Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolitesJ Clin Invest1982; 69: 1126-35.
98.
Utley JRRenal effects of cardiopulmonary bypass In: Utley JR ed. Pathophysiology and techniques of cardiopulmonary bypass , volume 1. Baltimore: Williams & Wilkins, 1982: 40-54.
99.
Shaw PJ, Bates D., Cartlidge Nef et al.Natural history of neurological complications of coronary bypass surgery: a sixth month follow-up studyBr Med J1986; 293 : 165-67.
100.
Shaw PJ, Bates D., Cartlidge Nef et al.Neuroopthalmological complications of coronary artery bypass graft surgeryActa Neurolog Scand1987; 99: 1-7.
101.
Harris Dnf , Bailey SM, Smith Plc et al.Brain swelling in the first hour after coronary artery bypass surgeryLancet1993: 342 : 586-87.
Cook DJ, Bryce RD, Oliver WC et al.Brain swelling after coronary artery surgeryLancet1993; 342 : 1370.
104.
Videm V., Fosse E., Mollnes TE et al.Different oxygenators for cardiopulmonary bypass lead to varying degrees of complement activationJ Thorac Cardiovasc Surg1989; 97 : 764-70.
105.
Gu YJ, van Oeveren W., Akkerman C., Boonstra PW, Huyzen RT, Wildevuur CRHeparin-coated circuits reduce the inflammatory response to cardiopulmonary bypassAnn Thorac Surg1993; 55: 917-22.
106.
Gillinov AM , De Valeria PA, Winkelstein JA et al.Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypassAnn Thorac Surg1993; 55 : 619-24.
107.
Moore Fdj, Warner KG, Assousa S. et al.The effects of compliment activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilutionAnn Surg1988; 208 : 95-103.
108.
Miyamoto Y1Hirose H., Matsuda H. et al.Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175Trans Am Soc AIO1989; 31 : 508-11.
109.
Anderson LW , Baek L., Thomsen BS et al.Effect of methylprednisolone on endotoxaemia and complement activation during cardiac surgeryJ Cardiothorac Anesth1989; 3: 544-49.
110.
Chiba Y., Muraoka R., Ihaya A., Morioka K., Sasaki M., Uesaka T.Leucocyte depletion and prevention of reperfusion injury during cardiopulmonary bypassCardiovasc Surg1993; 1: 350-56.
111.
Gillinov AM , Redmond JM, Zehr KJ et al.Inhibition of neutrophil adhesion during cardiopulmonary bypassAnn Thorac Surg1994; 57 : 126-33.
112.
Hill GE, Alonso A., Thiele GM, Robbins RAGlucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humansAnesth Analg1994; 79: 23-27.
113.
Mathew JP, Rinder CS, Tracey JR et al.Acadesine inhibits neutrophil CD11b up-regulation in vitro and during in vivo cardiopulmonary bypassJ Thorac Cardiovasc Surg1935; 109 : 448-56.
Dauber I., Welsh C., Weil JVCardiopulmonary bypass induced pulmonary and vascular injury is decreased by pentoxiphylline In: Mandel GL, Novick WJ eds. Pentoxiphylline and leukocyte function.Sommerville NJ: Hoechst-Roussel, 1988: 199-210.
116.
Menasche P. , Peynet J., Lariviere J. et al.Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions?Circulation1994; 90(11): 275-79.
117.
Verrier ED , Shen I.Potential role of neutrophil anti-adhesion therapy in myocardial stunning, myocardial infarction, and organ dysfunction after cardiopulmonary bypassJ Card Surg1993; 8: 309-12.
118.
Tracey KJ, Fong Y., Hesse DG et al.Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature1987; 330: 662-64.
119.
Ohlsson K. , Bjork P., Bergenfeldt M., Hageman R.Interleukin-1 receptor antagonist reduces mortality from endotoxic shockNature1990; 348 : 550-52.
120.
Bando K., Pillai R., Cameron DE et al.Leukocyte depletion ameliorates free radical mediated lung injury following cardiopulmonary bypassJ Thorac Cardiovasc Surg1990; 99 : 873-77.
121.
van der Selm TJ, Ansell DM, Okike ON et al.The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind, randomised trialJ Thorac Cardiovasc Surg1988 ; 95: 538-40.
122.
Del Rossi AJ, Cernaianu AC, Borros S. et al.Prophylactic treatment of postperfusion bleeding using EACAChest1988; 96: 27-30.
123.
Horrow JC, Hlavacek J., Strang MD et al.Prophylactic tranexamic acid decreases bleeding after cardiac operationsJ Thorac Cardiovasc Surg1990; 99: 70-74.
124.
Salzman EW , Weinstein MJ, Weintraub RM et al.Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trialN Engl J Med1986 : 314: 1402-406.
125.
Walker ID, Davidson JF, Faichney A. et al.A double-blind study of prostacyclin in cardiopulmonary bypass surgeryBr J Haematol1981: 49: 415-19.
126.
Teoh KH, Cristakis GT, Weisel RD et al.Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg1988; 96: 332-41.
127.
Efstratiadis T., Munsch C., Crossman D. et al.Aprotinin used in emergency coronary operation after streptokinase treatmentAnn Thorac Surg1991;52 :1320-21.
128.
van Oeveren W., Jansen Njg, Bidstrup BP et al. Effects of aprotinin on haemostatic mechanisms in cardiopulmonary bypassAnn Thorac Surg1987; 44 : 610-15.
129.
van Oeveren W., Eijsman L., Roozendaal KJ, Wildevuur Crh.Platelet preservation by aprotinin during cardiopulmonary bypassLancet1988; 2: 644-48.
130.
Hunt BJ, Cottam S., Segal H. et al.Inhibition of tPA-mediated fibrinolysis during orthotopic liver transplantationLancet1990; 336: 381-84.
131.
Tice DA, Worth M., Clauss RHThe inhibition by Trasylol of fibrinolytic activity associated with cardiovascular operationsSurg Gynecol Obstet1964 ; 119: 71-74.
132.
Tice DA, Reed GE, Clauss RH et al.Hemorrhage due to fibrinolysis occurring with open heart operationsJ Thorac Cardiovasc Surg1963; 46: 673-76.
133.
Mammen EFNatural protease inhibitors in extracorporeal circulationAnn NY Acad Sci1968; 146 :754-62.
134.
Bidstrup BP, Royston D., Sapsford RN, Taylor KMReduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)J Thorac Cardiovasc Surg1989; 97: 364-72.
135.
Royston D. , Bidstrup BP, Taylor KM, Sapsford RNEffect of aprotinin on need for blood transfusions after repeat open heart surgeryLancet1987 ; ii: 1289-91.
136.
Bidstrup BP , Royston D., Taylor KM, Sapsford RNEffect of aprotinin on need for blood transfusion in patients with septic endocarditis having open heart surgeryLancet1988; i: 366-67.
137.
Bidstrup BP , Harrison J., Royston D., Taylor KM, Treasure T.Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centres in the United KingdomAnn Thorac Surg1993; 55 : 971-76.
138.
Bidstrup BP , Royston D., McGuiness , Sapsford RN.Aprotinin reduces bleeding in patients taking aspirin at the time of open heart surgeryCirculation1989; 8: 158.
139.
Akhtar TM, Goodchild C., Boyen Mkg.Reversal of streptokinase-induced bleeding with aprotinin for emergency cardiac surgeryAnaesthesia1992; 47: 226-28.
140.
Dietrich W. , Spannagl M., Jochum M.Influence of high dose aprotinin treatment on blood loss and coagulation pattern in patients undergoing myocardial revascularizationAnaesthesia1990; 73: 1119-26.
141.
Blauhut B. , Gross C., Necek S. et al.Effects of high dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypassJ Thorac Cardiovasc Surg1991; 101: 958-67.
142.
Fraedrich G., Weber C., Bernard A. et al.Reduction of blood transfusion requirements in open heart surgery by administration of high dose aprotinin-preliminary resultsJ Thorac Cardiovasc Surg1989 ; 37: 89-91.
143.
Bidstrup BP , Underwood S., Sapsford RNThe effect of aprotinin (Trasylol) on aorto-coronary bypass graft patencyJ Thorac Cardiovasc Surg1993; 105(1): 147-53.